STOCK OPTION RESERVE (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
|---|
| Notes and other explanatory information [abstract] |
|
| Schedule of stock option reserve |
| Schedule of stock option
reserve |
|
|
|
|
|
|
|
|
| |
|
Years Ended March 31, |
| |
|
2026 |
|
2025 |
| |
|
|
|
|
| Balance, beginning of year |
|
$ |
23,530 |
|
|
$ |
23,841 |
|
| Share-based compensation expense |
|
|
1,745 |
|
|
|
321 |
(1) |
| Correction of prior period overstated share-based compensation
expense |
|
|
— |
|
|
|
(632 |
)(2) |
| Balance, end of year |
|
$ |
25,275 |
|
|
$ |
23,530 |
|
| (1) |
Amount is net of $0.6 million reversal of share-based compensation expense for unvested
share options forfeited during the fiscal year ended. |
| (2) |
Amount represents the correction as of March 31, 2025 for the overstated share-based compensation
expenses in Fiscal 2022 and Fiscal 2024. |
|
| Schedule of share options issued and outstanding |
| Schedule of share options issued
and outstanding |
|
|
|
|
|
|
|
|
| |
|
Years Ended March 31, |
| |
|
2026 |
|
2025 |
| Balance, beginning of period |
|
|
225,117 |
|
|
|
90,281 |
|
| Granted |
|
|
2,028,135 |
|
|
|
160,000 |
|
| Expired or forfeited |
|
|
(6,745 |
) |
|
|
(25,164 |
) |
| Balance, end of period |
|
|
2,246,507 |
|
|
|
225,117 |
|
| Exercisable, end of period |
|
|
2,246,507 |
|
|
|
102,855 |
|
| Available for future awards |
|
|
— |
|
|
|
17,516 |
|
|
| Schedule of weighted-average estimated fair value of share options |
| Schedule of weighted-average estimated
fair value of share options |
|
|
|
|
|
|
|
|
| |
|
Years Ended March 31, |
| |
|
2026 |
|
2025 |
| Grant Price |
|
|
1.30 |
|
|
|
4.45 |
|
| Expected life (in years) |
|
|
10 |
|
|
|
5.75 |
|
| Risk-free interest rates |
|
|
3.68 |
% |
|
|
4.14 |
% |
| Volatility |
|
|
115.0 |
% |
|
|
135.8 |
% |
| Dividend yield |
|
|
— |
|
|
|
— |
|
|
| Schedule of weighted average exercise price and the remaining contractual life |
| Schedule of weighted average exercise price and the remaining
contractual life |
|
|
|
|
| |
|
As of March 31, |
| |
|
2026 |
|
2025 |
| Weighted average exercise price |
|
$ |
6.84 |
|
|
$ |
62.51 |
|
| Weighted average remaining contractual life (in years) |
|
|
9.9 |
|
|
|
9.1 |
|
|
| Schedule of Share options granted and outstanding |
| Schedule of Share options granted and
outstanding |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
Share Options as of |
| Grant Date |
|
Expiration Date |
|
Exercise Price $ |
|
March 31, 2026 |
| January 13, 2021 |
|
January
13, 2031 |
|
|
355.00 |
|
|
|
21,400 |
|
| January 19, 2022 |
|
January
19, 2032 |
|
|
204.40 |
|
|
|
12,475 |
|
| February 15, 2022 |
|
February
15, 2032 |
|
|
171.80 |
|
|
|
— |
|
| June 8, 2022 |
|
June
8, 2032 |
|
|
220.00 |
|
|
|
— |
|
| July 27, 2022 |
|
July
27, 2032 |
|
|
201.20 |
|
|
|
— |
|
| March 30, 2023 |
|
March
30, 2033 |
|
|
58.40 |
|
|
|
24,497 |
|
| March 7, 2025 |
|
March
7, 2035 |
|
|
4.45 |
|
|
|
160,000 |
|
| July 27, 2025 |
|
July
27, 2025 |
|
|
5.73 |
|
|
|
97,739 |
|
| March 11, 2026 |
|
March
11, 2036 |
|
|
1.30 |
|
|
|
1,930,396 |
|
| Total |
|
|
|
|
|
|
|
|
2,246,507 |
|
|